An official website of the United States government
NIH Guide: Weekly Index for September 15, 2023
Weekly NIH Funding Opportunities and Notices
September 15, 2023
Policy Notices
-
NIH Final Updated Policy Guidance for Subaward/Consortium Written Agreements
(NOT-OD-23-182)National Institutes of Health
General Notices
-
Notice of Pre-Application Webinar for RFA-AG-24-033, State Dementia Care Research Center (U54 Clinical Trial Not Allowed)
(NOT-AG-23-046)National Institute on Aging
-
Notice to Inform the Extramural Influenza Research Community of the Availability of Materials for Controlled Human Influenza Virus Infection Model (CHIVIM) Clinical Studies and Trials
(NOT-AI-23-067)National Institute of Allergy and Infectious Diseases
-
Notice of Pre-Application Webinar for PAR-23-244: Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
(NOT-CA-23-091)National Cancer Institute
-
Notice of pre-Application Technical Assistance Webinar for RFA-DE-24-003 Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed)
(NOT-DE-23-016)National Institute of Dental and Craniofacial Research
-
Notice of Pre-Application Webinar for the PAR-23-248, Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
(NOT-DK-23-032)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Challenge Announcement: RADx Tech Fetal Monitoring Challenge
(NOT-EB-23-017)National Institute of Biomedical Imaging and BioengineeringEunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice announcing HEAL Initiative Technical Assistance Webinar: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain: Acute Pain Clinical Trials Program (U01 Clinical Trials and U24 Resource and Data Center)
(NOT-HD-23-025)Eunice Kennedy Shriver National Institute of Child Health and Human Development
-
Notice of Technical Assistance Webinar and FAQs for NOT-HL-23-113 (NOSI): Promoting implementation research to address HIV-associated comorbidities and risk factors within well-established longitudinal studies (R01 CT Optional)
(NOT-HL-23-111)National Heart, Lung, and Blood Institute
-
Consolidated Notice on NIMH Clinical Trials Policies
(NOT-MH-23-375)National Institute of Mental Health
-
Pre-Application Webinar for RFA-NR-24-001: Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional)
(NOT-NR-23-017)National Institute of Nursing Research
-
Findings of Research Misconduct
(NOT-OD-23-181)Office of the Director, NIH
-
RESCINDED - Notice of NIH Participation in the NIH-NSF Ecology and Evolution of Infectious Diseases Program
(NOT-TW-23-007)John E. Fogarty International CenterNational Institute of Allergy and Infectious DiseasesNational Institute of General Medical Sciences
-
Request for Information (RFI): Inviting Comments and Suggestions on Opportunities and Challenges for the Collection, Use, and Sharing of Real-World Data (RWD) including Electronic Health Records, for NIH Supported Biomedical and Behavioral Research
(NOT-OD-23-180)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of Correction to Letter of Intent Due Dates in PAR-23-256 Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
(NOT-AT-24-013)National Center for Complementary and Integrative Health
-
Notice of Correction to RFA-HD-24-007, Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01 Clinical Trial Optional)".
(NOT-CA-23-088)National Cancer Institute
-
Notice of Correction to RFA-CA-23-042, The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
(NOT-CA-23-090)National Cancer Institute
-
Notice of Change to Funding Opportunity AHRQ Health Services Research Dissertation Program (R36)
(NOT-HS-23-022)Agency for Healthcare Research and Quality
-
Notice of Correction to Page Limitation Instructions and Clarification for Milestones and Timeline Instructions in RFA-RM-23-012 Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional)
(NOT-RM-23-024)Office of Strategic Coordination (Common Fund)
Notices of Special Interest
-
Notice of Special Interest (NOSI): Advancing Rheumatic Heart Disease Research (R01)
(NOT-HL-23-106)National Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA)
Program: Collaborative and Innovative Acceleration Award (UG3/UH3) (Clinical Trial Optional) for Advancing Recruitment through Trial Innovation Network (AR-TIN)
(NOT-TR-23-026)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesNational Human Genome Research Institute
Funding Opportunities
-
NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
(PAR-23-275)National Institute of Allergy and Infectious DiseasesNational Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): January 7, 2025
-
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
(PAR-23-285)National Institute on Drug AbuseNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Nursing ResearchNational Center for Complementary and Integrative HealthOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionApplication Receipt Date(s): Multiple dates, see announcement.
-
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
(PAR-23-298)National Institute on Drug AbuseNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Biomedical Imaging and BioengineeringOffice of Research on Women's HealthOffice of Behavioral and Social Sciences ResearchOffice of Disease PreventionNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Multiple dates, see announcement.
-
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
(PAR-23-300)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): May 21, 2025
-
HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R01 Clinical Trial Optional)
(RFA-AA-23-005)National Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Center for Complementary and Integrative HealthApplication Receipt Date(s): December 14, 2023
-
HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R34 Clinical Trial Optional)
(RFA-AA-23-006)National Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Center for Complementary and Integrative HealthApplication Receipt Date(s): December 14, 2023
-
Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed)
(RFA-AI-23-056)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): January 26, 2024
-
Cohort Studies of HIV/AIDS and Substance Use (U01 Clinical Trial Not Allowed)
(RFA-DA-25-003)National Institute on Drug AbuseApplication Receipt Date(s): Not Applicable
-
Center for Exposome Research Coordination to Accelerate Precision Environmental Health (U24 Clinical Trial Not Allowed)
(RFA-ES-23-010)National Institute of Environmental Health SciencesNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Cancer InstituteNational Institute of Neurological Disorders and StrokeOffice of Research on Women's HealthEnvironmental influences on Child Health OutcomesApplication Receipt Date(s): November 30, 2023
-
Building an Integrated Laboratory System to Advance the Safety of Human and Animal Food
(RFA-FD-24-004)Food and Drug AdministrationApplication Receipt Date(s): October 23, 2023, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this NOFO.
-
Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Program (HVP) (U24 Clinical Trial Not Allowed)
(RFA-RM-23-016)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): November 29, 2023
-
Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts (U01 Clinical Trial Not Allowed)
(RFA-RM-23-017)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): November 15, 2023
-
Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed)
(RFA-RM-23-018)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): November 14, 2023
-
Human Virome Characterization Centers (U54 Clinical Trial Not Allowed)
(RFA-RM-23-019)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): November 17, 2023
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster